Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Triggering receptor expressed on myeloid cells (TREM‐2) is a membrane receptor associated with DAP12 that is expressed primarily in myeloid cells, including dendritic cells and microglia, and promotes fusion of osteoclast precursors into multinucleated cells. A rare autosomal recessive condition, Nasu‐Hakola disease (NHD) is associated with loss‐of‐function mutations in DAP12 and TREM‐2. The brain pathology observed in NHD patients suggests that disruption of the TREM‐2/DAP12 pathway leads to neurodegeneration with demyelination and axonal loss. In this study, we have characterized TREM‐2 protein expression on microglia using a newly produced monoclonal antibody directed against the mouse TREM‐2 receptor. We report that TREM‐2 expression is up‐regulated in the spinal cord during both the early inflammatory and chronic phases of myelin oligodendrocyte glycoprotein (MOG)35–55 peptide‐induced experimental autoimmune encaphalomyelitis (EAE). We also demonstrate that TREM‐2 is highly expressed on microglial cells in the central nervous system (CNS) during EAE and that blockade of TREM‐2 during the effector phase of EAE results in disease exacerbation with more diffuse CNS inflammatory infiltrates and demyelination in the brain parenchyma. These results demonstrate a critical role for TREM‐2 during inflammatory responses in the CNS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These studies further support a role for microglia in the phagocytosis of myelin debris and potentially in subsequent axonal remyelination.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [254]
In the citing paper
“TREM-2 is an important receptor involved in phagocytosis, and upon genetic absence or blockade of TREM-2, microglia fail to upregulate genes required for lipid metabolism and phagocytosis, resulting in the exacerbation of EAE [254, 255] (Table 6).”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [254]
In the citing paper
“Indeed, in EAE it has been shown that TREM2 is upregulated in spinal cord microglia and that an anti-TREM2 antibody exacerbates disease172.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [172]
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Plat-E: an efficient and stable system for transient packaging of retroviruses
Morita, S., Kojima, T., & Kitamura, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301206 · Cited by 1,660
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Bouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284
Self-citationAloisi, F. (2001) · Glia · doi:10.1002/glia.1106 · Cited by 1,280
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862
TREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701
Self-citation
Cited by
Items 201–287 of 287
Cerebrospinal fluid biomarkers as predictors of multiple sclerosis severity
Tolentino, M., Pace, F., Perantie, D. C., Mikesell, R., Huecker, J., Chahin, S., Ghezzi, L., Piccio, L., & Cross, A. H. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106268 · Cited by 11
Self-citationByrne, N. J., Lee, A. C., Kostas, J. C., Reid, J. C., Partridge, A. T., So, S., Cowan, J. E., Abeywickrema, P. D., Huang, H., Zebisch, M., et al. (2020) · Protein Expression and Purification · doi:10.1016/j.pep.2020.105796 · Cited by 11
Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis
Fernández-Paredes, L., de Diego, R. P., de Andrés, C., & Sánchez‐Ramón, S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9665-5 · Cited by 12
“lipid-laden macrophages—cells with an anti-inflammatory role in the CNS—whereas TREM-1 is expressed by macrophages in active demyelinatingMS lesions [53].”
BackgroundInfluentialJu, W.-Y., Wang, Q., Song, L.-J., Ding, Z., Li, X., Kumar, G., Yan, Y., & Ma, C. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07968-z · Cited by 12
Research and progress on biomarkers of neuromyelitis optica spectrum disorders
Wang, J., Liu, J., Li, R., & Wang, C. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1830109 · Cited by 11
“Studies [18]have demonstrated that for AQP4-IgG positive NMOSD cases, the level of GFAP in CSF (604.2 ng/ml (0.45–57,906 ng/ ml)) was significantly higher than that in MOG-IgG positive NMOSD group (0.0035–6.86 ng/ml), and even higher than that in MS group (0.54 ng/ml (0.25–1.59 ng/ml)).”
BackgroundResultInfluentialDou, Z., Guo, Y., Liu, J., Li, N., Chai, B., Li, X., Fu, R., & Wang, X. (2016) · PubMed Central · Cited by 10
Greer, R. A., Tuckey, R. A., Dean, H. B., Brett, T. J., Roberson, E. D., & Song, Y. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70729 · Cited by 9
Borim, P. A., Mimura, L. A. N., Zorzella-Pezavento, S. F. G., Polonio, C. M., Peron, J. P. S., Sartori, A., & Fraga‐Silva, T. F. D. C. (2022) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2021.0206 · Cited by 9
Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic Review
Schmitz, K., Geißlinger, G., & Tegeder, I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091992 · Cited by 10
“Sci. 2017, 18, 1992 11 of 18 functions and soluble Trem2 is increased in cerebrospinal fluid (CSF) of MS patients [71].”
BackgroundHall, H. T. L., Sjolin-Goodfellow, H. E., Brauner, H., Tomasello, E., Dalod, M., Vivier, É., & Höglund, P. (2008) · European Journal of Immunology · doi:10.1002/eji.200838259 · Cited by 10
Davis, D. S., & Carson, M. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_1 · Cited by 9
Que, X., Zhang, T., Liu, X. Y., Yin, Y., Xia, X., Gong, P., Song, W., Qin, Q., Xu, Q., & Tang, Y. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102732 · Cited by 8
“Functional blockade of TREM2 exacerbates inflammation and demyelination (Piccio et al., 2007), while TREM2 deficiency diminishes the ability to maintain neural homeostasis, and leads to uncontrolled increases in neuroinflammatory responses through increased lysosomal activity (Gao et al., 2023).”
Sterile innate immune mechanisms in neurodegenerative diseases
Ealy, A., Serapiglia, A. M., & Panicker, N. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111039 · Cited by 8
“Both the EAE model of MS and cuprizone demyelination model have shown TREM2 facilitates removal of myelin debris and increases remyelination (236, 237).”
BACE1 influences debris clearance and axonal regeneration in injured peripheral nerve
Farah, M. H. (2012) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2012.00428.x · Cited by 8
“TREM2 on membrane of macrophages is believed to be the active form and cell surface TREM2 is associated with phagocytosis (Turnbull et al., 2006; Piccio et al., 2007; Hsieh et al., 2009).”
BackgroundThe Emerging Role of Microglial Hv1 as a Target for Immunomodulation in Myelin Repair
Tang, Y., Wu, X., Li, J., Li, Y., Xu, X., Li, G., Zhang, P., Qin, C., Wu, L., Tang, Z., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.1107 · Cited by 12
“Blockage of TREM2 results in increased demyelination in EAE [107].”
BackgroundTian, M.-L., Ni, X.-N., Li, J., Tan, C., Cao, X., Tan, L., & Initiative, A. D. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00742 · Cited by 6
Lipidomics Analysis of Human HMC3 Microglial Cells in an In Vitro Model of Metabolic Syndrome
Chmielarz, M., Bromke, M. A., Olbromski, M., Środa-Pomianek, K., Frej−Mądrzak, M., Dzięgiel, P., & Sobieszczańska, B. (2024) · Biomolecules · doi:10.3390/biom14101238 · Cited by 6
“The results demonstrated that LPS in HMC3 cells pre-stimulated with TNF α enhanced Trem2 expression, contradicting the results of Piccio et al. [55], in which cultured microglia treated with LPS at a concentration of 1 mg/mL for 30 min completely down-regulated the expression of Trem2 .”
ResultThe Role of TREM2 After Stroke: From Mechanisms to Therapeutic Potential
Zhou, T., Chen, A., Sun, Y., Huang, B., Xu, Y., & He, Q. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05622-w · Cited by 7
Abugaliyeva, A., & Rasool, S. (2023) · Brain Disorders · doi:10.1016/j.dscb.2023.100110 · Cited by 6
Synthetic cleavage-resistant TREM2 boosts macrophage efferocytosis to treat inflammatory diseases
Dong, X., Zhao, X., Gao, J., Bo, L., Li, Y., Kong, Z., 孙维绎, Xu, X., Liu, Z., Xiu, Q., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102580 · Cited by 15
“1,2 21 In Alzheimer’s disease (AD) models, elevating TREM2 in microglia enhanced amyloid phagocytosis, reduced neuroinflammation, and improved cognitive performance, underscoring its critical role in neural homeostasis.”
Chen, B., Lu, H.-C., Huang, L., Wang, J., Bujold, M., Tang, L., Du, X., & Wang, Y. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03733-2 · Cited by 6
“The importance of TREM2 in AD and MS disease modulation has been shown in studies using transgenic models [18–23].”
Niu, W., Ma, L., Tao, T., Tian, F., He, T., Qiao, M., He, H., Liu, X., & Zhao, X. (2020) · Acta Histochemica · doi:10.1016/j.acthis.2020.151553 · Cited by 6
Immunology of Multiple Sclerosis
Wu, G. F., & Cross, A. H. (2021) · Springer eBooks · doi:10.1007/978-3-030-61883-4_9 · Cited by 5
Self-citationWang, X., Hu, J., Xie, S., Li, W., Zhang, H., Huang, L., Qian, Z., Zhao, C., & Hu, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113024 · Cited by 6
Who is who within the universe of TREM-like transcripts (TREML)?
Ertel, M. V., da Silva, A. B. A., de Sousa, D. F., dos Santos, C. J., da Silva, T. M., Silva‐Sales, M., Matos, A. D. O., & Sales‐Campos, H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122696 · Cited by 5
Bibliometric Analysis of TREM2 (2001-2022): Trends, Hotspots and Prospects in Human Disease
Qian, M., Zhong, J., Lu, Z., Zhang, W., Weng, M., Zhang, K., & Jin, Y. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.96851 · Cited by 5
“Research on brain and various neurological diseases such as Alzheimer's disease, multiple sclerosis and experimental autoimmune encephalitis also commenced during this period [31-33].”
BackgroundAlrouji, M., Yasmin, S., Alhumaydhi, F. A., Sharaf, S. E., Shahwan, M. J., & Shamsi, A. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2317987 · Cited by 6
“TREM2 is a transmembrane glycoprotein primarily expressed on microglia, the resident immune cells of the central nervous system (CNS) (Piccio et al., 2007).”
Possible role of microgliopathy in the pathogenesis of Nasu–Hakola disease
Satoh, J. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12046 · Cited by 4
“view, direct blockade of TREM2 by a neutralizing antibody exacerbates experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS).(20) In contrast, intravenous administration of TREM2-transduced myeloid cells promotes the recovery of EAE by facilitating the clearance of myelin debris.”
BackgroundBasic Science of Central Nervous System Infections
Tessier, J. M., & Scheld, W. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00040-x · Cited by 3
Microglial Neurotransmitter Receptors in Health and Disease
Bi, Q., Guo, C., Chen, N., Zhou, X., Zhou, Q., Liu, X., Shen, X. Z., & Shi, P. D. (2026) · Physiology · doi:10.1152/physiol.00030.2025 · Cited by 3
Temporal Dynamics of APOE and TREM2 Expression in Microglial Activation of NMOSD Mouse Models
Xu, S., Dai, W., Wang, T., Cao, S., Du, J., Pang, X., Li, Q., & Tian, Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05160-5 · Cited by 3
“TREM2 is a critical regulator of microglial immune function and is closely associated with microglial activation [33, 34].”
Brunois, C., & Ris, L. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_9 · Cited by 2
TRAPC : A novel Triggering Receptor expressed on Antigen Presenting Cells
van der Holst, R. (2007) · Figshare · Cited by 2
Harnessing the microbiome to regulate myeloid TREM2 expression and innate immune responses
Mihori, S., Nichols, F. C., Jellison, E. R., Blesso, C. N., Graziano, V. R., Rathinam, V. A. K., & Clark, R. B. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlaf073 · Cited by 1
Fissolo, N., Benkert, P., Vilaseca, A., Blanco, Y., Hegen, H., Berek, K., Miralles, F. C. P., Rejdak, K., Villar, L. M., Monreal, E., et al. (2026) · European Journal of Neurology · doi:10.1111/ene.70480 · Cited by 1
Yang, Y. P., Su, X., Zhuang, Z., Hu, P., Wang, M., Liao, Z., Yang, P., & Hu, J. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.5.67 · Cited by 1
“29 Xie et al. demonstrated that TREM2 deficiency impaired microglial phagocytosis, exacerbating neuronal damage and motor deficits in amyotrophic lateral sclerosis.”
Microglial Function in MS Pathology
Kilpatrick, T. J., & Jokubaitis, V. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2218-1_3 · Cited by 1
Hoogland, I. C. M., Yik, J., Westhoff, D., Engelen-Lee, J.-Y., Seron, M. V., Man, W. K., Houben-Weerts, J. H. P. M., Tanck, M. W. T., van Westerloo, D. J., van der Poll, T., et al. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136894 · Cited by 1
“The second signaling stream suppresses pro-inflammatory cytokine production and secretion [8].”
BackgroundNeurotropic murine coronavirus mediated demyelination: Factors dampening pathogenesis
Hwang, M., & Bergmann, C. C. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578382 · Cited by 1
ADAM17 Inhibition Protects Cognition in Intermittent Hypoxia: The Role of TREM2
Xu, J., Jin, H., Li, X., Jiang, Z., Meng, F., Wang, W., & Li, W. (2025) · Nature and Science of Sleep · doi:10.2147/nss.s513304 · Cited by 1
“31,32 Our previous study observed an elevated level of serum sTREM2 in OSA patients, which was associated with MoCA and nocturnal hypoxemia.”
Alvarez‐Cermeño, J. C., Gasalla, T., & Villar, L. C. (2009) · Future Neurology · doi:10.2217/14796708.4.2.149 · Cited by 1
Trem2 Variants and Risk of Alzheimer’s Disease
Andres, P. M. D. (2014) · Brain Disorders & Therapy · doi:10.4172/2168-975x.1000127 · Cited by 1
“Increased expression of TREM2 on microglia is coupled to enhanced phagocytic pathways and promotes the alternative activation state of microglia, which is thought to be protective [6-8].”
Microglial Biology and Physiology
Butovsky, O., Madore, C., & Weiner, H. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_13 · Cited by 2
Importance of Microglial Cytoskeleton and the Actin-interacting Proteins in Alzheimer's Disease
Choi, G.-E. (2020) · Biomedical Science Letters · doi:10.15616/bsl.2020.26.1.1 · Cited by 1
“TREM-2 in microglial cells leads to the reconstitution of F-actin and phosphorylation of extracellular signal regulated kinase (ERK) / mitogen activated protein kinase (MAPK) through binding to DNAX activating protein 12 (DAP12) to mediate the removal of apoptotic neurons (Takahashi et al., 2005; Piccio et al., 2007).”
BackgroundCarbajosa, G., Malki, K., Lawless, N., Wang, H., Ryder, J. W., Wozniak, E., Wood, K., Mein, C. A., Hodgkinson, A., Dobson, R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.16.452732 · Cited by 2
Chen, X., Le, Y., He, W., He, J., Wang, Y., Zhang, L., Xiong, Q., Zheng, X., & Wang, H. (2021) · Research Square · doi:10.21203/rs.3.rs-671471/v1 · Cited by 2
Vastrad, B. M., & Vastrad, C. M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.27.501664 · Cited by 1
Vastrad, B. M., & Vastrad, C. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.01.543204 · Cited by 2
Neuraminidase 1 regulates the cellular state of microglia by modulating the sialylation of Trem2Preprint
Fremuth, L. E., Hu, H., van de Vlekkert, D., Annunziata, I., Weesner, J. A., Gomero, E. M., & d’Azzo, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.20.595036 · Cited by 1
TREM-2 expression and regulation in inflammation and ischaemia
Bradley, J. (2014) · UEA Digital Repository (University of East Anglia)
Effects of Macrophages and Monocytes in Remyelination of the CNS
Natrajan, M. S., Bielekova, B., & Franklin, R. J. M. (2015) · Wiley eBooks · doi:10.1002/9781118732748.ch13
P2‐030: INVESTIGATING THE ROLE OF CLU, PICALM, AND CR1 IN ALZHEIMER'S DISEASE
Lord, J., Turton, J. C., Braae, A., Barber, I., Medway, C., Brown, K. S., & Morgan, K. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.703
Kiialainen, A. (2007) · Helda - University of Helsinki Institutional Repository
Diabetes Pathogenesis - Role of Natural Killer Cells, T Cells and a Novel Neuropeptide
Brauner, H. (2010) · Figshare
Hoffman, P., & Wong, P. (2011)
Einfluss des immunsuppressiven Peptids von HIV-1 auf die Genexpression in humanen Immunzellen
Ryu, H. (2009) · Publication server of the Robert Koch Institute (Robert Kock Institute) · doi:10.25646/5309
Review Article Microglia and ischemic stroke: a double-edged sword
Patel, A. R., Ritzel, R. M., McCullough, L. D., & Liu, F. (2013)
Giannetti, P. (2015) · Spiral (Imperial College London) · doi:10.25560/34680
Mayrhofer, F., Dariychuk, Z., Zhen, A., Daugherty, D. J., Bannerman, P. G. C., Hanson, A. M., Pleasure, D., Soulika, A. M., Deng, W., & Chechneva, O. V. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/396036
Ding, Z., Han, Q.-X., Song, L., Wang, Q., Han, G., Chu, G.-G., Li, Y., Chai, Z., Yu, J., Xiao, B., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-531893/v1 · Cited by 1
“The blockade of TREM2 during the progression of EAE led to disease deterioration with more in ammatory reactivity and demyelination in the CNS (Piccio et al. 2007).”
BackgroundActivation of Microglia and Macrophages in Neurodegenerative Diseases
Salamero‐Boix, A., Schulz, M., & Sevenich, L. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_2
chen, X., Le, Y., Tang, S., He, W., He, J., Wang, Y., & Wang, H. (2021) · Research Square · doi:10.21203/rs.3.rs-671471/v2 · Cited by 1
Emerging Roles of TREM2 in Neurodegenerative Diseases
Kabir, M. T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_7
Fröhlich, A., Heuvel, F. O., Rehman, R., Krishnamurthy, S. S., Li, S., Li, Z., Bayer, D., Conquest, A., Hagenston, A. M., Ludolph, A. C., et al. (2022) · DZNE Pub · doi:10.6084/m9.figshare.21601436
Fröhlich, A., Heuvel, F. O., Rehman, R., Krishnamurthy, S. S., Li, S., Li, Z., Bayer, D., Conquest, A., Hagenston, A. M., Ludolph, A. C., et al. (2022) · DZNE Pub · doi:10.6084/m9.figshare.21601433
Fröhlich, A., Heuvel, F. O., Rehman, R., Krishnamurthy, S. S., Li, S., Li, Z., Bayer, D., Conquest, A., Hagenston, A. M., Ludolph, A. C., et al. (2022) · DZNE Pub · doi:10.6084/m9.figshare.21601442
Ribeiro, A. R., Pereira, R., Barros, C., Barateiro, A. P., Alberro, A., Basto, A. P., Graça, L., Pinto, M. V., Santos, F. M. F., Góis, P. M. P., et al. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10195-5
“Moreover, TREM2 blockage in an EAE model resulted in disease exacerbation with more CNS inflammation and demyelination (Piccio et al. 2007).”
Vastrad, B. M., Pattanashetti, S., & Vastrad, C. M. (2025) · Research Square · doi:10.21203/rs.3.rs-7964384/v1
Bullous Pemphigoid Develops Independently of DAP12
Pigors, M., Patzelt, S., Brudey, M., Emtenani, S., Khil’chenko, S., Kamaguchi, M., Reichhelm, N., Parker, M., Bieber, K., Ludwig, R. J., et al. (2025) · Biomolecules · doi:10.3390/biom15111549 · Cited by 1
“…in DAP12 − / − mice [21], and inhibition of the DAP12 signaling pathway reduces neutrophil activation in rheumatoid arthritis [29], paradoxically, other studies, have reported increased susceptibility to experimentally induced diabetes and autoimmune encephalomyelitis in DAP12 − / − mice [30,31].”
Guadalupi, L., Vanni, V., Balletta, S., Caioli, S., Vito, F. D., Fresegna, D., Sanna, K., Nencini, M., Donninelli, G., Volpe, E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25824812
Fröhlich, A., Heuvel, F. O., Rehman, R., Krishnamurthy, S. S., Li, S., Li, Z., Bayer, D., Conquest, A., Hagenston, A. M., Ludolph, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21601421
Fröhlich, A., Heuvel, F. O., Rehman, R., Krishnamurthy, S. S., Li, S., Li, Z., Bayer, D., Conquest, A., Hagenston, A. M., Ludolph, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21601439
Fröhlich, A., Heuvel, F. O., Rehman, R., Krishnamurthy, S. S., Li, S., Li, Z., Bayer, D., Conquest, A., Hagenston, A. M., Ludolph, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21601427
Fröhlich, A., Heuvel, F. O., Rehman, R., Krishnamurthy, S. S., Li, S., Li, Z., Bayer, D., Conquest, A., Hagenston, A. M., Ludolph, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21601403
Fröhlich, A., Heuvel, F. O., Rehman, R., Krishnamurthy, S. S., Li, S., Li, Z., Bayer, D., Conquest, A., Hagenston, A. M., Ludolph, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21601415
Guadalupi, L., Vanni, V., Balletta, S., Caioli, S., Vito, F. D., Fresegna, D., Sanna, K., Nencini, M., Donninelli, G., Volpe, E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26720076
Guadalupi, L., Vanni, V., Balletta, S., Caioli, S., Vito, F. D., Fresegna, D., Sanna, K., Nencini, M., Donninelli, G., Volpe, E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25824769
Fröhlich, A., Heuvel, F. O., Rehman, R., Krishnamurthy, S. S., Li, S., Li, Z., Bayer, D., Conquest, A., Hagenston, A. M., Ludolph, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21601424
Chang, C. L. (2010) · theses.fr (ABES) · doi:10.70675/c6eb9cbaz95c6z4ed0zb7bfze36084b6e6db · Cited by 1
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Mechanisms controlling microglial colonization of the forebrain
Bridlance, C. (2023) · theses.fr (ABES) · doi:10.70675/5879aa36z8649z48f9zb359zf349ce3cb429
Kong, Z., Shen, L., Ma, D., & Hou, J. (2026) · Clinical and Translational Discovery · doi:10.1002/ctd2.70140 · Cited by 1
Wang, H., Wen, R., Parker, E., & Yang, L. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03083-9 · Cited by 4
“This exacerbates symptoms in experimental MS models (e.g., EAE) and causes defects in OL maturation [63].”
Metadata
- Authors
- Piccio, L., Buonsanti, C., Mariani, M., Cella, M., Gilfillan, S., Cross, A. H., Colonna, M., & Panina‐Bordignon, P.
- Affiliations
- University of Milan (IT)
- Washington University in St. Louis (US)
- Corresponding author
- Panina‐Bordignon, Paola
- ORCID
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2007-04-19
- Volume
- 37
- Issue
- 5
- Pages
- 1290-1301
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2090134990
- Cited by
- 284
- References
- 51
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 16 · 2023: 13 · 2022: 25 · 2021: 20 · 2020: 17 · 2019: 14 · 2018: 21 · 2017: 16 · 2016: 17 · 2015: 14 · 2014: 27 · 2013: 17 · 2012: 9
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREM2, DAP12, experimental autoimmune encephalomyelitis, microglia, demyelination, myelin oligodendrocyte glycoprotein, Nasu-Hakola disease, neuroinflammation, monoclonal antibodies, myeloid cells
- MeSH terms
- Animals, Brain, Encephalomyelitis, Autoimmune, Experimental, Fluorescent Antibody Technique, Macrophages, Membrane Glycoproteins, Receptors, Immunologic, RNA, Messenger, Spinal Cord, Blotting, Northern, Up-Regulation, Microglia, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.